|Issuer:||SORRENTO THERAPEUTICS, INC. (SRNE)|
|Original Submission Date:|
SMITH ROBIN L
C/O SORRENTO THERAPEUTICS, INC.
4955 DIRECTORS PLACE SAN DIEGO, CA 92121
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|f1||the price reported in column 4 is a weighted average price. these shares were purchased in multiple transactions at prices ranging from $2.145 to $2.42, inclusive. the reporting person undertakes to provide upon request by the staff of the securities and exchange commission, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.|